Measuring symptoms and test results in eosinophilic gut diseases
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 3 years old or older (any sex)
- Your biopsy biopsy results show eosinophil inflammation in the gut, meeting specific numbers in certain areas (esophagus or parts of the small/large intestine)
- If you are newly diagnosed, you have gut symptoms (if previously diagnosed, symptoms are not required)
- You do not have prior bowel/intestinal surgery other than a G-tube placement
- You are not in another blinded (placebo/unknown) research study at your first visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children ages 0–18 with eosinophilic gut disorders (EGIDs) to better understand these conditions and how they are managed. It may help doctors improve care by comparing real-world information from patients followed at participating hospitals.
This study builds a registry of children with eosinophilic gastrointestinal (gut) disorders (EGIDs) and also includes children being evaluated for possible EGIDs. It may help doctors better understand these conditions and improve future care.
This study looks at how inflamed the esophagus is in children who have eosinophilic esophagitis (EoE). It may help doctors better understand what’s driving symptoms like trouble swallowing and food getting stuck.
This trial looks at taking a small tissue sample during a routine endoscopy to better understand eosinophilic esophagitis (EoE). It may help doctors learn how to diagnose and track EoE more easily.
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
Hear when a new Eosinophilic Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.